Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

9.870 +0.090 (+0.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,427,085
Open 9.820
Bid (Size) 9.870 (190)
Ask (Size) 9.880 (9)
Prev. Close 9.780
Today's Range 9.750 - 9.980
52wk Range 6.685 - 10.68
Shares Outstanding 1,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 of Wall Street’s Favorite Stocks We Find Risky
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply concerns. 
Via Benzinga
Topics Government World Trade

Performance

YTD
+27.2%
+27.2%
1 Month
+1.3%
+1.3%
3 Month
+19.8%
+19.8%
6 Month
+34.1%
+34.1%
1 Year
+13.4%
+13.4%

More News

Read More
1 Small-Cap Stock with Competitive Advantages and 2 We Turn Down
Via StockStory
Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)
From Kashiv BioSciences, LLC and Amneal Pharmaceuticals, Inc. and Alvotech and Advanz Pharma
Via Business Wire
Earnings Scheduled For August 5, 2025
Via Benzinga
A Peek at Amneal Pharmaceuticals's Future Earnings
Via Benzinga
3 Lesser-Known Healthcare Names With Major Upside in Store
Via MarketBeat
Amneal to Report Third Quarter 2025 Results on October 30, 2025
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Pharma Stock Rises On FDA Approval For Generic Version Of AbbVie’s Eyedrops
Via Stocktwits
Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
3 Low-Volatility Stocks We Find Risky
Via StockStory
Topics Economy Government World Trade
Why Amneal (AMRX) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence Economy
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
From Amneal Pharmaceuticals LLC
Via GlobeNewswire
3 Hyped Up Stocks with Open Questions
Via StockStory
1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down
Via StockStory
Topics Bonds
Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know
Via StockStory
Topics Artificial Intelligence Economy
AMRX Q2 Deep Dive: New Product Launches and Specialty Momentum Shape Guidance
Via StockStory
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know
Via StockStory
Topics Bonds Economy Stocks
1 Value Stock to Keep an Eye On and 2 Facing Challenges
Via StockStory
Amneal (AMRX) Q2 EPS Jumps 56%
Via The Motley Fool
Topics Economy
Amneal Pharmaceuticals Inc (NASDAQ:AMRX) Reports Mixed Q2 2025 Results: Earnings Beat, Revenue Miss
Via Chartmill
Topics Earnings
Amneal (NASDAQ:AMRX) Misses Q2 Sales Targets
Via StockStory
Amneal Reports Second Quarter 2025 Financial Results
From Amneal Pharmaceuticals LLC
Via GlobeNewswire

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 9.870
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 10/16/25 04:00 PM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 9.87K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 10K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.